A detailed history of Winton Group LTD transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Winton Group LTD holds 13,373 shares of TMDX stock, worth $1.59 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
13,373
Previous 32,740 59.15%
Holding current value
$1.59 Million
Previous $2.2 Million 18.62%
% of portfolio
0.1%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$67.67 - $143.04 $1.31 Million - $2.77 Million
-19,367 Reduced 59.15%
13,373 $1.79 Million
Q1 2025

May 15, 2025

BUY
$56.73 - $79.42 $870,862 - $1.22 Million
15,351 Added 88.28%
32,740 $2.2 Million
Q4 2024

Feb 12, 2025

BUY
$59.28 - $144.9 $1.03 Million - $2.52 Million
17,389 New
17,389 $1.08 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $3.79B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.